Thank you for participating in our presentation. Complete this survey to move on to the CE page.

Q1Number of patients seen per month with COPD?
 1-10 11-20 21-30 31-40 41-50 Over 50
Q2Please rate the following:
 Unsatisfactory Needs Improvement Average Above Average Excellent
 Degree to which educational expectations were met    
 Material was relevant to my practice    
 Effective Faculty Presenter    
 Overall Program    
Q3Please rate your ability to achieve the Learning Objectives below:
 Not at all Somewhat Mostly Completely
 Collaborate with patients to inform treatment decision-making that addresses their symptoms and concerns   
 Individualize guideline-recommended therapy to reduce COPD exacerbations, improve lung function, and manage daily symptoms, such as breathlessness   
 Select an inhaler and optimal dose of inhalant that best meets a patient’s needs and capabilities   
Q4As a result of what you have learned during this program, will you change your practice behaviors?
 Definitely Not Unlikely Not Sure Probably Absolutely
Q7Did the content contribute valuable information that will assist in improving patient outcomes?
 Strongly Disagree Disagree Neutral Agree Strongly Agree
Q8What was your level of expertise on this topic?
 None Little Some Considerable Extensive
 BEFORE this presentation    
 AFTER this presentation    
Q9Do you believe the activity was fair and balanced, free from commercial influences?
 Yes No
Q10Did the program increase your competence?
 Yes No
Q11A key objective of shared decision-making is to...
Q12According to GOLD 2020, the goal of treatment for patients with stable COPD is to...
Q13How confident are you in your answer to the last question?
 Not at all Somewhat Confident Very confident
Q14Which type of inhaler is best avoided in a patient who is able to inhale quickly, but has difficulty with coordinating actuation and inhalation?
 Breath-activated pressurized metered dose inhaler Dry powder inhaler Pressurized metered dose inhaler Soft-mist inhaler

dividing line